Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

A seven-year-old boy, diagnosed with X-linked Adrenoleukodystrophy (X-ALD) that is a rare and often fatal genetic disorder, has made a rema.

Kidney transplant recipients receiving the investigational cellular product MDR-101 achieved functional immune tolerance for ...

MiNK Therapeutics surged on tumor remission data for agenT-797, but financial risks and limited clinical proof remain. Learn ...

MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease ...

Kidney transplant recipients who receive donor-derived hematopoietic stem cells may be able to discontinue immunosuppressive ...

Shares of MiNK Therapeutics, Inc. (INKT) skyrocketed on Friday following the publication of a case from its clinical trial ...

Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...